Accelerant price target raised to $18 from $15 at Piper Sandler

Piper Sandler raised the firm’s price target on Accelerant (ARX) to $18 from $15 and keeps an Overweight rating on the shares. The firm still thinks the long-term prospects for the insurance brokers are excellent but in the near term are incrementally less optimistic about the brokers. Further, Piper believes the defensive nature of the sector along with margins around all-time highs make the sector attractive as a defensive play. However, organic growth is decelerating, and the firm expects it will continue to decelerate throughout 2026.